A Review of Asymptomatic and Subclinical Middle East Respiratory Syndrome Coronavirus Infections
- PMID: 31781765
- PMCID: PMC7108493
- DOI: 10.1093/epirev/mxz009
A Review of Asymptomatic and Subclinical Middle East Respiratory Syndrome Coronavirus Infections
Abstract
The epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) since 2012 has been largely characterized by recurrent zoonotic spillover from dromedary camels followed by limited human-to-human transmission, predominantly in health-care settings. The full extent of infection of MERS-CoV is not clear, nor is the extent and/or role of asymptomatic infections in transmission. We conducted a review of molecular and serological investigations through PubMed and EMBASE from September 2012 to November 15, 2018, to measure subclinical or asymptomatic MERS-CoV infection within and outside of health-care settings. We performed retrospective analysis of laboratory-confirmed MERS-CoV infections reported to the World Health Organization to November 27, 2018, to summarize what is known about asymptomatic infections identified through national surveillance systems. We identified 23 studies reporting evidence of MERS-CoV infection outside of health-care settings, mainly of camel workers, with seroprevalence ranges of 0%-67% depending on the study location. We identified 20 studies in health-care settings of health-care worker (HCW) and family contacts, of which 11 documented molecular evidence of MERS-CoV infection among asymptomatic contacts. Since 2012, 298 laboratory-confirmed cases were reported as asymptomatic to the World Health Organization, 164 of whom were HCWs. The potential to transmit MERS-CoV to others has been demonstrated in viral-shedding studies of asymptomatic MERS infections. Our results highlight the possibility for onward transmission of MERS-CoV from asymptomatic individuals. Screening of HCW contacts of patients with confirmed MERS-CoV is currently recommended, but systematic screening of non-HCW contacts outside of health-care facilities should be encouraged.
Keywords: MERS-CoV; health-care workers; infection control; seroprevalence; subclinical infections.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.
Figures
Similar articles
-
Middle East respiratory syndrome coronavirus transmission among health care workers: Implication for infection control.Am J Infect Control. 2018 Feb;46(2):165-168. doi: 10.1016/j.ajic.2017.08.010. Epub 2017 Sep 25. Am J Infect Control. 2018. PMID: 28958446 Free PMC article.
-
The prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies in dromedary camels in Israel.Zoonoses Public Health. 2018 Sep;65(6):749-754. doi: 10.1111/zph.12482. Epub 2018 May 31. Zoonoses Public Health. 2018. PMID: 29855166 Free PMC article.
-
Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review.Travel Med Infect Dis. 2019 Jan-Feb;27:27-32. doi: 10.1016/j.tmaid.2018.12.003. Epub 2018 Dec 11. Travel Med Infect Dis. 2019. PMID: 30550839 Free PMC article.
-
Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction.Pathog Glob Health. 2015;109(8):354-62. doi: 10.1080/20477724.2015.1122852. Pathog Glob Health. 2015. PMID: 26924345 Free PMC article. Review.
-
Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission.Lancet Infect Dis. 2018 Aug;18(8):e217-e227. doi: 10.1016/S1473-3099(18)30127-0. Epub 2018 Apr 18. Lancet Infect Dis. 2018. PMID: 29680581 Free PMC article. Review.
Cited by
-
New endemic and pandemic pathologies with interhuman airborne transmission through ear, nose and throat anatomical sites.Acta Otorhinolaryngol Ital. 2022 Apr;42(Suppl. 1):S5-S13. doi: 10.14639/0392-100X-suppl.1-42-2022-01. Acta Otorhinolaryngol Ital. 2022. PMID: 35763270 Free PMC article.
-
The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.J Clin Virol. 2020 Jul;128:104397. doi: 10.1016/j.jcv.2020.104397. Epub 2020 Apr 30. J Clin Virol. 2020. PMID: 32388472 Free PMC article.
-
A comparative overview of COVID-19, MERS and SARS: Review article.Int J Surg. 2020 Sep;81:1-8. doi: 10.1016/j.ijsu.2020.07.032. Epub 2020 Jul 26. Int J Surg. 2020. PMID: 32730205 Free PMC article. Review.
-
Low-Level Middle East Respiratory Syndrome Coronavirus among Camel Handlers, Kenya, 2019.Emerg Infect Dis. 2021;27(4):1201-1205. doi: 10.3201/eid2704.204458. Emerg Infect Dis. 2021. PMID: 33754992 Free PMC article.
-
Individual Immune Response to SARS-CoV-2 Infection-The Role of Seasonal Coronaviruses and Human Leukocyte Antigen.Biology (Basel). 2023 Sep 28;12(10):1293. doi: 10.3390/biology12101293. Biology (Basel). 2023. PMID: 37887003 Free PMC article.
References
-
- World Health Organization WHO MERS Global Summary and Assessment of Risk: August 2018. Geneva, Switzerland: World Health Organization; 2018http://www.who.int/csr/disease/coronavirus_infections/risk-assessment-au.... Accessed November 18, 2018.
-
- Zaki AM, van Boheemen S, Bestebroer TM, et al. . Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–1820. - PubMed
-
- Hijawi B, Abdallat M, Sayaydeh A, et al. . Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J. 2013;19(suppl 1):S12–S18. - PubMed